ANI Pharmaceuticals | ANIP - Ebitda





Ebitda Alterar Data
AbbVie USD 5.37B 1.85B 2025-12
ANI Pharmaceuticals USD 65.36M 5.76M 2025-12
Aurora Cannabis CAD 18.48M 3.11M 2025-12
Canopy Growth CAD -2.87M 19.49M 2025-12
Eli Lilly USD 12.14B 4.26B 2025-12
Heron Therapeutics USD -3.88M 5.63M 2024-09
Hikma Pharmaceutical USD 369M 84M 2024-12
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Nektar Therapeutics USD -31.81M 70K 2023-09
Novartis USD 5.84B 235M 2025-09
Omeros USD -47.96M 7.39M 2023-09
Perrigo USD 141.6M 1.34B 2026-03
Sun Pharmaceuticals INR 39.54B 9.94B 2026-03
Teva Pharmaceutical Industries USD 1.06B 582M 2026-03